Literature DB >> 17939903

Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures.

Pasquale Niscola1, Alessio Pio Perrotti, Giovanni del Poeta, Claudio Romani, Massimiliano Palombi, Daniela Piccioni, Laura Scaramucci, Barbara Tolu, Andrea Tendas, Luca Cupelli, Elisabetta Abruzzese, Gianna Maria D'Elia, Gregorio Antonio Brunetti, Luca Maurillo, Marco Giovannini, Claudio Cartoni, Paolo de Fabritiis.   

Abstract

Varicella zoster virus (VZV) outbreak is a significant cause of morbidity in patients suffering from blood-related malignancies, occurring mostly among those affected by lymphoproliferative disorders and in those receiving haematopoietic stem-cell transplantation. The elucidated pathological mechanisms of VZV-related painful complications have provided the rationale for acute zoster pain (AZP) and post-herpetic neuralgia (PHN) treatment with antiviral therapy combined with neuroactive agents, such as tricyclic or anticonvulsant agents. The role of opioids in this setting is less clearly established. We successfully treated (with oxycodone) 12 consecutive patients suffering from AZP and long-lasting PHN resistant to several agents, including anticonvulsants and analgesics. Our experience is reported together with a brief overview of the management of these often distressing and intractable complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939903

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  1 in total

1.  Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.

Authors:  Claudio Cartoni; Gregorio Antonio Brunetti; Vincenzo Federico; Fabio Efficace; Sara Grammatico; Andrea Tendas; Laura Scaramucci; Luca Cupelli; Gianna Maria D'Elia; Andrea Truini; Pasquale Niscola; Maria Teresa Petrucci
Journal:  Support Care Cancer       Date:  2012-06-15       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.